[ RECIPIENT ENTITY RECORD ]

Rare Disease Therapeutics

VERIFIED NODE ID: 002601 · rare-disease-therapeutics
R TARGET NODE — CAPITAL RECIPIENT
Rare Disease Therapeutics
SPV France
Recipient Type
SPV
Primary Jurisdiction
France
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Rare Disease Therapeutics
Entity Type SPV
Jurisdiction France
Recipient Intelligence Summary

Rare Disease Therapeutics represents the pharmaceutical manufacturing facility dedicated to producing specialized treatments for orphan conditions and genetic disorders. Based in Europe, the site supports the global supply chain for high-value biologic medicines. It is a primary recipient of institutional healthcare capital through strategic industry acquisitions.

Capital Influx Log (Transactions)
Date Type Amount
03 Jun 2026 EQUITY $1.7B